Percutaneous Coronary Intervention Utilization and Appropriateness across the United States

• Michael P. Thomas ,

  * E-mail: michptho@med.umich.edu

  Affiliations Cardiovascular Medicine, University of Michigan, Ann Arbor, Michigan, United States of America, Cardiovascular Medicine, VA Ann Arbor Healthcare System, Ann Arbor, Michigan, United States of America

  ⨯
• Craig S. Parzynski,

  Affiliation Cardiovascular Medicine, Yale School of Medicine, New Haven, Connecticut, United States of America

  ⨯
• Jeptha P. Curtis,

  Affiliation Cardiovascular Medicine, Yale School of Medicine, New Haven, Connecticut, United States of America

  ⨯
• Milan Seth,

  Affiliation Cardiovascular Medicine, University of Michigan, Ann Arbor, Michigan, United States of America

  ⨯
• Brahmajee K. Nallamothu,

  Affiliations Cardiovascular Medicine, University of Michigan, Ann Arbor, Michigan, United States of America, Cardiovascular Medicine, VA Ann Arbor Healthcare System, Ann Arbor, Michigan, United States of America

  ⨯
• Paul S. Chan,

  Affiliation Saint Luke’s Mid America Heart and Vascular Institute, Kansas City, Missouri, United States of America

  ⨯
• John A. Spertus,

  Affiliation Saint Luke’s Mid America Heart and Vascular Institute, Kansas City, Missouri, United States of America

  ⨯
• Manesh R. Patel,

  Affiliation Duke Clinical Research Institute, Durham, North Carolina, United States of America

  ⨯
• Steven M. Bradley,

  Affiliation Cardiovascular Medicine, University of Colorado and VA Eastern Colorado Healthcare System, Denver, Colorado, United States of America

  ⨯
• Hitinder S. Gurm

  Affiliations Cardiovascular Medicine, University of Michigan, Ann Arbor, Michigan, United States of America, Cardiovascular Medicine, VA Ann Arbor Healthcare System, Ann Arbor, Michigan, United States of America

  ⨯